ICD-10: E11
Type 2 diabetes mellitus
Clinical Information
Includes
- diabetes (mellitus) due to insulin secretory defect
- insulin resistant diabetes (mellitus)
- diabetes NOS
Additional Information
Description
Type 2 diabetes mellitus, classified under ICD-10 code E11, is a chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency. This condition is prevalent worldwide and is associated with various complications if not managed effectively. Below is a detailed clinical description and relevant information regarding this diagnosis.
Clinical Description of Type 2 Diabetes Mellitus (E11)
Definition and Pathophysiology
Type 2 diabetes mellitus (T2DM) is primarily characterized by the body's inability to effectively use insulin, a hormone that regulates blood glucose levels. Unlike Type 1 diabetes, where the body fails to produce insulin, individuals with T2DM typically produce insulin but their cells do not respond to it adequately, leading to elevated blood glucose levels. Over time, the pancreas may also produce less insulin, exacerbating the condition[1][2].
Risk Factors
Several risk factors contribute to the development of T2DM, including:
- Obesity: Excess body fat, particularly around the abdomen, is a significant risk factor.
- Sedentary Lifestyle: Lack of physical activity can increase the risk of developing insulin resistance.
- Genetics: A family history of diabetes can increase susceptibility.
- Age: The risk increases with age, particularly after 45 years.
- Ethnicity: Certain ethnic groups, including African Americans, Hispanic Americans, Native Americans, and some Asian Americans, are at higher risk[3][4].
Symptoms
Common symptoms of T2DM may include:
- Increased thirst and frequent urination
- Extreme fatigue
- Blurred vision
- Slow-healing sores or frequent infections
- Areas of darkened skin, usually in the armpits and neck[5].
Diagnosis
Diagnosis of T2DM is typically made through:
- Fasting Plasma Glucose Test: A fasting blood sugar level of 126 mg/dL or higher indicates diabetes.
- Oral Glucose Tolerance Test: A blood sugar level of 200 mg/dL or higher two hours after drinking a glucose solution indicates diabetes.
- A1C Test: An A1C level of 6.5% or higher confirms the diagnosis[6].
Complications
If left untreated, T2DM can lead to serious complications, including:
- Cardiovascular Disease: Increased risk of heart attack and stroke.
- Neuropathy: Nerve damage, particularly in the feet, leading to pain or loss of sensation.
- Nephropathy: Kidney damage that can lead to kidney failure.
- Retinopathy: Damage to the eyes that can result in blindness.
- Foot Damage: Poor circulation and nerve damage can lead to serious foot infections[7][8].
Management and Treatment
Management of T2DM involves a combination of lifestyle changes, monitoring, and medication:
- Lifestyle Modifications: Diet and exercise are crucial. A balanced diet low in refined sugars and high in fiber, along with regular physical activity, can help manage blood sugar levels.
- Medications: Various medications may be prescribed, including metformin, sulfonylureas, and insulin therapy, depending on the severity of the condition and individual patient needs[9].
- Monitoring: Regular monitoring of blood glucose levels is essential to ensure they remain within target ranges.
Conclusion
Type 2 diabetes mellitus (ICD-10 code E11) is a complex condition that requires comprehensive management to prevent complications. Understanding its clinical features, risk factors, and treatment options is vital for effective patient care. Regular follow-up and patient education are key components in managing this chronic disease, ensuring that individuals can lead healthy lives while effectively controlling their blood sugar levels.
For further information or specific queries regarding coding and documentation for T2DM, healthcare professionals can refer to the ICD-10-CM/PCS MS-DRG definitions manual and relevant coding guides[10].
Clinical Information
Type 2 diabetes mellitus (ICD-10 code E11) is a chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency. Understanding its clinical presentation, signs, symptoms, and patient characteristics is crucial for effective diagnosis and management. Below is a detailed overview of these aspects.
Clinical Presentation
Overview
Type 2 diabetes typically develops gradually and may go unnoticed for years. It is often diagnosed during routine medical examinations or when complications arise. The clinical presentation can vary significantly among individuals, influenced by factors such as age, duration of the disease, and the presence of comorbid conditions.
Common Signs and Symptoms
Patients with type 2 diabetes may exhibit a range of symptoms, which can be categorized into classic symptoms and those associated with complications.
Classic Symptoms
- Polyuria: Increased urination due to elevated blood glucose levels leading to osmotic diuresis.
- Polydipsia: Excessive thirst resulting from dehydration caused by fluid loss through urination.
- Polyphagia: Increased hunger, as the body is unable to utilize glucose effectively for energy.
- Fatigue: A common complaint due to the body’s inability to use glucose for energy.
- Blurred Vision: Fluctuations in blood sugar levels can affect the lens of the eye, leading to temporary vision changes.
Additional Symptoms
- Weight Loss: Although more common in type 1 diabetes, some patients with type 2 diabetes may experience unexplained weight loss.
- Slow Healing of Wounds: Impaired circulation and nerve function can lead to delayed healing.
- Frequent Infections: Increased susceptibility to infections, particularly urinary tract infections and skin infections.
- Tingling or Numbness: Peripheral neuropathy can cause sensations of tingling or numbness, particularly in the feet.
Patient Characteristics
Demographics
- Age: Type 2 diabetes is more prevalent in adults, particularly those over 45 years of age, although it is increasingly being diagnosed in younger populations, including children and adolescents, due to rising obesity rates.
- Ethnicity: Certain ethnic groups, including African Americans, Hispanic Americans, Native Americans, and some Asian Americans, are at higher risk for developing type 2 diabetes.
Risk Factors
- Obesity: A significant risk factor, particularly central obesity, which is associated with insulin resistance.
- Sedentary Lifestyle: Lack of physical activity contributes to weight gain and insulin resistance.
- Family History: A genetic predisposition can increase the likelihood of developing type 2 diabetes.
- Hypertension and Dyslipidemia: Coexisting conditions such as high blood pressure and abnormal lipid levels are common in patients with type 2 diabetes.
Comorbid Conditions
Patients with type 2 diabetes often present with other health issues, including:
- Cardiovascular Disease: Increased risk of heart disease and stroke.
- Chronic Kidney Disease: Diabetes is a leading cause of kidney failure.
- Retinopathy: Diabetic eye disease can lead to vision loss.
- Neuropathy: Nerve damage can result in pain, tingling, or loss of sensation.
Conclusion
Type 2 diabetes mellitus (E11) presents with a variety of symptoms and patient characteristics that can significantly impact quality of life. Early recognition of symptoms such as polyuria, polydipsia, and fatigue, along with awareness of risk factors like obesity and family history, is essential for timely diagnosis and management. Regular monitoring and comprehensive care can help mitigate complications associated with this chronic condition, ultimately improving patient outcomes.
Approximate Synonyms
Type 2 diabetes mellitus, classified under the ICD-10 code E11, is a complex metabolic disorder characterized by insulin resistance and relative insulin deficiency. This condition is commonly referred to by various alternative names and related terms that reflect its clinical features, complications, and management. Below is a detailed overview of these terms.
Alternative Names for Type 2 Diabetes Mellitus
-
Non-Insulin Dependent Diabetes Mellitus (NIDDM): This term emphasizes that individuals with type 2 diabetes typically do not require insulin therapy for management, especially in the early stages of the disease.
-
Adult-Onset Diabetes: Historically, type 2 diabetes was often referred to as adult-onset diabetes because it primarily developed in adults. However, due to rising obesity rates, it is increasingly being diagnosed in children and adolescents.
-
Diabetes Mellitus Type 2: This is a straightforward alternative that specifies the type of diabetes, distinguishing it from type 1 diabetes mellitus (ICD-10 code E10).
-
Insulin Resistance Diabetes: This term highlights one of the primary pathophysiological mechanisms of type 2 diabetes, where the body's cells become resistant to the effects of insulin.
-
Metabolic Syndrome: While not synonymous, type 2 diabetes is often associated with metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke, and diabetes.
Related Terms and Concepts
-
Hyperglycemia: This term refers to elevated blood glucose levels, a common feature of type 2 diabetes. The specific ICD-10 code for type 2 diabetes with hyperglycemia is E11.65.
-
Diabetic Complications: Type 2 diabetes can lead to various complications, including:
- Diabetic Neuropathy: Nerve damage due to prolonged high blood sugar levels.
- Diabetic Retinopathy: Eye damage that can lead to blindness.
- Diabetic Nephropathy: Kidney damage that can result in kidney failure. -
Insulin Sensitivity: This term describes how responsive the body’s cells are to insulin. In type 2 diabetes, insulin sensitivity is often reduced.
-
Glycemic Control: This refers to the management of blood glucose levels in individuals with diabetes, which is crucial for preventing complications.
-
Oral Hypoglycemic Agents: These are medications used to manage type 2 diabetes, which help lower blood sugar levels without the need for insulin.
-
Lifestyle Modifications: This term encompasses dietary changes, physical activity, and weight management strategies that are essential for managing type 2 diabetes.
Conclusion
Understanding the alternative names and related terms for ICD-10 code E11 (Type 2 diabetes mellitus) is crucial for healthcare professionals, patients, and researchers alike. These terms not only facilitate better communication but also enhance the understanding of the condition's complexities and management strategies. As the prevalence of type 2 diabetes continues to rise globally, awareness of these terms will aid in education and treatment efforts.
Diagnostic Criteria
The diagnosis of Type 2 diabetes mellitus, classified under ICD-10 code E11, involves a combination of clinical criteria and laboratory tests. Understanding these criteria is essential for accurate diagnosis and appropriate coding. Below is a detailed overview of the diagnostic criteria for Type 2 diabetes mellitus.
Diagnostic Criteria for Type 2 Diabetes Mellitus
1. Symptoms of Hyperglycemia
Patients may present with classic symptoms of hyperglycemia, which include:
- Increased thirst (polydipsia)
- Frequent urination (polyuria)
- Increased hunger (polyphagia)
- Fatigue
- Blurred vision
These symptoms can prompt further testing to confirm the diagnosis of diabetes mellitus.
2. Blood Glucose Testing
The diagnosis of Type 2 diabetes is primarily confirmed through blood glucose testing. The following criteria are used:
-
Fasting Plasma Glucose (FPG) Test: A fasting plasma glucose level of 126 mg/dL (7.0 mmol/L) or higher. Fasting is defined as no caloric intake for at least 8 hours.
-
Oral Glucose Tolerance Test (OGTT): A 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher during a 75 g oral glucose tolerance test.
-
Random Plasma Glucose Test: A random plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis.
-
Hemoglobin A1c Test: An A1c level of 6.5% (48 mmol/mol) or higher. This test reflects average blood glucose levels over the past 2 to 3 months.
3. Confirmatory Testing
If the initial test results indicate diabetes, a confirmatory test is recommended unless the patient presents with unequivocal hyperglycemia. This is to ensure accuracy and avoid misdiagnosis. Confirmatory testing can be done on a different day or through repeat testing of the same type.
4. Exclusion of Other Conditions
It is important to rule out other types of diabetes, such as Type 1 diabetes or secondary diabetes due to other medical conditions or medications. This may involve assessing the patient's medical history, family history, and conducting additional tests as necessary.
5. Consideration of Risk Factors
While not a diagnostic criterion, the presence of risk factors can guide the need for testing. Risk factors for Type 2 diabetes include:
- Obesity (BMI ≥ 30 kg/m²)
- Sedentary lifestyle
- Family history of diabetes
- Age (≥ 45 years)
- History of gestational diabetes or delivering a baby weighing more than 9 pounds
- Hypertension or dyslipidemia
Conclusion
The diagnosis of Type 2 diabetes mellitus (ICD-10 code E11) is based on a combination of clinical symptoms and specific laboratory tests that measure blood glucose levels. Accurate diagnosis is crucial for effective management and treatment of the condition. Healthcare providers must ensure that the criteria are met and consider the patient's overall health and risk factors when diagnosing and coding for Type 2 diabetes mellitus[1][2][3][4][5].
Treatment Guidelines
Type 2 diabetes mellitus (ICD-10 code E11) is a chronic condition characterized by insulin resistance and relative insulin deficiency. The management of this condition involves a multifaceted approach that includes lifestyle modifications, pharmacotherapy, and regular monitoring. Below is a detailed overview of the standard treatment approaches for Type 2 diabetes.
Lifestyle Modifications
Diet
A balanced diet is crucial for managing Type 2 diabetes. Key dietary recommendations include:
- Carbohydrate Management: Focus on complex carbohydrates with a low glycemic index to help control blood sugar levels. This includes whole grains, legumes, fruits, and vegetables.
- Portion Control: Monitoring portion sizes can help prevent overeating and manage weight.
- Healthy Fats: Incorporate sources of healthy fats, such as avocados, nuts, and olive oil, while limiting saturated and trans fats.
- Regular Meal Timing: Eating at regular intervals can help maintain stable blood glucose levels.
Physical Activity
Regular physical activity is essential for managing Type 2 diabetes. Recommendations include:
- Aerobic Exercise: Aim for at least 150 minutes of moderate-intensity aerobic activity per week, such as brisk walking or cycling.
- Strength Training: Include resistance exercises at least twice a week to improve muscle mass and insulin sensitivity.
Weight Management
Achieving and maintaining a healthy weight is critical. Even a modest weight loss of 5-10% can significantly improve blood sugar control and reduce the risk of complications.
Pharmacotherapy
When lifestyle modifications alone are insufficient to control blood glucose levels, pharmacotherapy is initiated. The following classes of medications are commonly used:
1. Metformin
- First-line Treatment: Metformin is typically the first medication prescribed for Type 2 diabetes. It works by decreasing hepatic glucose production and improving insulin sensitivity.
- Benefits: It is associated with weight neutrality or modest weight loss and has cardiovascular benefits.
2. Sulfonylureas
- Mechanism: These medications stimulate the pancreas to release more insulin.
- Examples: Glipizide, glyburide, and glimepiride are commonly used sulfonylureas.
3. DPP-4 Inhibitors
- Function: Dipeptidyl peptidase-4 (DPP-4) inhibitors enhance incretin levels, which help regulate insulin secretion.
- Examples: Sitagliptin, saxagliptin, and linagliptin.
4. GLP-1 Receptor Agonists
- Action: These medications mimic the incretin hormone, promoting insulin secretion and reducing appetite.
- Examples: Liraglutide, semaglutide, and dulaglutide.
5. SGLT2 Inhibitors
- Mechanism: Sodium-glucose co-transporter 2 (SGLT2) inhibitors prevent glucose reabsorption in the kidneys, leading to increased glucose excretion.
- Examples: Canagliflozin, empagliflozin, and dapagliflozin.
6. Insulin Therapy
- Indications: Insulin may be required for patients with significant hyperglycemia or those who do not achieve adequate control with oral medications.
- Types: Various insulin formulations are available, including long-acting, short-acting, and premixed insulins.
Monitoring and Follow-Up
Regular monitoring of blood glucose levels is essential for effective management. Key components include:
- Self-Monitoring: Patients are encouraged to regularly check their blood glucose levels to understand their response to treatment.
- A1C Testing: Hemoglobin A1C tests should be performed at least twice a year to assess long-term glucose control.
- Regular Check-Ups: Routine visits to healthcare providers for comprehensive evaluations, including assessments of kidney function, eye health, and cardiovascular risk factors.
Conclusion
The management of Type 2 diabetes mellitus (ICD-10 code E11) requires a comprehensive approach that combines lifestyle changes, pharmacotherapy, and regular monitoring. By adhering to these standard treatment strategies, individuals with Type 2 diabetes can effectively manage their condition, reduce the risk of complications, and improve their overall quality of life. Continuous education and support from healthcare professionals are vital in empowering patients to take an active role in their diabetes management.
Related Information
Description
- Chronic metabolic disorder characterized by insulin resistance
- Relative insulin deficiency results in elevated blood glucose levels
- Insulin resistance leads to pancreas producing less insulin over time
- Obesity is a significant risk factor for developing T2DM
- Sedentary lifestyle increases the risk of developing insulin resistance
- Genetics and age are also contributing factors to T2DM development
- Common symptoms include increased thirst, frequent urination, fatigue
- Diagnosis typically made through fasting plasma glucose test or A1C test
Clinical Information
- Polyuria increased urination due to high glucose
- Polydipsia excessive thirst from fluid loss through urination
- Polyphagia increased hunger from ineffective glucose use
- Fatigue common complaint due to energy imbalance
- Blurred Vision temporary vision changes from fluctuating blood sugar
- Weight Loss unexplained weight loss in some patients
- Slow Healing of Wounds delayed healing from impaired circulation and nerve function
- Frequent Infections increased susceptibility to infections
- Tingling or Numbness peripheral neuropathy causing sensations
- Obesity significant risk factor particularly central obesity
- Sedentary Lifestyle lack of physical activity contributes to weight gain and insulin resistance
- Family History genetic predisposition increases likelihood of developing type 2 diabetes
- Hypertension and Dyslipidemia coexisting conditions common in patients with type 2 diabetes
Approximate Synonyms
- Non-Insulin Dependent Diabetes Mellitus (NIDDM)
- Adult-Onset Diabetes
- Diabetes Mellitus Type 2
- Insulin Resistance Diabetes
- Metabolic Syndrome
- Hypoglycemia
Diagnostic Criteria
- Hunger and thirst increase
- Frequent urination is common
- Blurred vision may occur
- Fasting glucose >126 mg/dL
- OGTT glucose >200 mg/dL
- Random glucose >200 mg/dL
- A1c level ≥6.5%
- Exclude Type 1 diabetes
- Consider risk factors: obesity, sedentary lifestyle
Treatment Guidelines
- Dietary changes focus on complex carbohydrates
- Portion control is crucial for weight management
- Incorporate healthy fats like avocados and nuts
- Aerobic exercise recommended at least 150 minutes weekly
- Strength training improves muscle mass and insulin sensitivity
- Metformin is typically the first medication prescribed
- Sulfonylureas stimulate pancreas to release more insulin
- DPP-4 inhibitors enhance incretin levels for insulin regulation
- GLP-1 receptor agonists promote insulin secretion and reduce appetite
- SGLT2 inhibitors increase glucose excretion through kidneys
- Insulin therapy may be required for significant hyperglycemia
- Regular A1C testing assesses long-term glucose control
- Self-monitoring of blood glucose levels is essential
Coding Guidelines
Use Additional Code
- oral antidiabetic drugs (Z79.84)
- code to identify control using:
- injectable non-insulin antidiabetic drugs (Z79.85)
- insulin (Z79.4)
- oral hypoglycemic drugs (Z79.84)
Excludes 1
- postprocedural diabetes mellitus (E13.-)
- neonatal diabetes mellitus (P70.2)
- drug or chemical induced diabetes mellitus (E09.-)
- postpancreatectomy diabetes mellitus (E13.-)
- type 1 diabetes mellitus (E10.-)
- secondary diabetes mellitus NEC (E13.-)
- gestational diabetes (O24.4-)
- diabetes mellitus due to underlying condition (E08.-)
Subcategories
Related Diseases
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.